The role of Rezum in the management of refractory urinary retention due to benign prostate hyperplasia: A literature review

References

• Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol. 1984; 132:474–479. PubMed] [Google Scholar] [Ref list.
   PubMed Web of Science ®Google Scholar
• Jm D, Aeddula NR. Male urinary retention. 2021 Jul 10. [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 30860734. In: StatPearls.
   Google Scholar
• Foster HE, Barry MJ, Dahm P, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol. 2018 September;200(3):A1-A30,467–668.
   Web of Science ®Google Scholar
• Mishriki SF, Grimsley SJS, Nabi G, et al. Improved quality of life and enhanced satisfaction after TURP: prospective 12-year follow-up study. Urology. 2008;72(2):322–326. [Crossref], [PubMed], [Web of Science ®], [Google Scholar]
   PubMed Web of Science ®Google Scholar
• Sagen E, Namnuan RO, Hedelin H, et al. The morbidity associated with a TURP procedure in routine clinical practice, as graded by the modified Clavien-Dindo system. Scand J Urol. 2019 Aug;53(4):240–245. Epub 2019 Jun 3. PMID: 31156002.
   PubMed Web of Science ®Google Scholar
• Senior K. Age and comorbidity status predict post-TURP mortality. Nat Rev Urol. 2009;6(463). 10.1038/nrurol.2009.163
   Google Scholar
• Chung ASJ, Woo HH. Update on minimally invasive surgery and benign prostatic hyperplasia. Asian J Urol. 2018;5(1):22–27.
   PubMed Web of Science ®Google Scholar
• Nair SM, Pimentel MA, Gilling PJ. Evolving and investigational therapies for benign prostatic hyperplasia. Can J Urol. 2015;22(Suppl.1):5. [PubMed] [Google Scholar] [Ref list].
   Google Scholar
• McVary KT, Gange SN, Gittelman MC, et al. Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016;195:1529–1538. [PubMed] [Google Scholar] [Ref list].
   PubMed Web of Science ®Google Scholar
• Dixon C, Cedano ER, Pacik D, et al. Efficacy and safety of Rezūm system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2015 Nov;86(5):1042–1047. Epub 2015 Jul 26. PMID: 26216644.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
   PubMed Web of Science ®Google Scholar
• Higgins JPGS. Cochrane handbook for systematic reviews of interventions: the cochrane collaboration. 2011. cited 2018 Jan 30. Available from: www.cochrane-handbook.org
   Google Scholar
• JAC S, MA H, BC R, et al. ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ. 2016;355:i4919.
   PubMedGoogle Scholar
• Bole R, Gopalakrishna A, Kuang R, et al. Comparative postoperative outcomes of Rezūm prostate ablation in patients with large versus small Glands. J Endourol. 2020 Jul;34(7):778–781. Epub 2020 Jun 12. PMID: 32408768.
   PubMed Web of Science ®Google Scholar
• Bassily D, Wong V, Phillips JL, et al. Rezūm for retention-retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia. Prostate. 2021 Oct;81(14):1049–1054. Epub 2021 Jul 20. PMID: 34287992.
   PubMed Web of Science ®Google Scholar
• Alegorides C, Fourmarier M, Eghazarian C, et al. Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: results at one year. Prog Urol. 2020 Oct;30(12):624–631. Epub 2020 Aug 18. PMID: 32826195.
   PubMed Web of Science ®Google Scholar
• Eredics K, Wehrberger C, Henning A, et al. Rezūm water vapor therapy in multimorbid patients with urinary retention and catheter dependency. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):302–305. Epub 2021 Sep 29. PMID: 34588631.
   PubMed Web of Science ®Google Scholar
• Wong A, Mahmalji W. The role of Rezūm ™ team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review. Aging Male. 2020 Dec 5;23:1620–1626. Epub 2021 Apr 5.
   PubMed Web of Science ®Google Scholar
• McVary KT, Rogers T, Roehrborn CG. Rezūm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology. 2019Apr; 126: 171–179 Epub 2019 Jan 21. PMID: 30677455
   PubMed Web of Science ®Google Scholar
• Groves HK, Chang D, Palazzi K, et al. The incidence of acute urinary retention secondary to BPH is increasing among California men. Prostate Cancer Prostatic Dis. 2013;16:260–265.
   PubMed Web of Science ®Google Scholar
• Lin YH, Hou CP, Chen TH, et al. Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction. BMC Geriatr. 2018;18(15). 10.1186/s12877-018-0709-3
   Google Scholar
• Karavitakis M, Kyriazis I, Omar MI, et al. Management of urinary retention in patients with benign prostatic obstruction: a systematic review and meta-analysis. Eur Urol. 2019 May;75(5):788–798. Epub 2019 Feb 14. PMID: 30773327.
   PubMed Web of Science ®Google Scholar
• Tanneru K, Jazayeri SB, Alam MU, et al. An indirect comparison of newer minimally invasive treatments for benign prostatic hyperplasia: a network meta-analysis model. J Endourol. 2021 Apr;35(4):409–416. Epub 2021 Jan 25. PMID: 32962442.
   PubMed Web of Science ®Google Scholar
• Blanchard K, Hananel A, Rutchik S, et al. Transurethral resection of the prostate: failure patterns and surgical outcomes in patients with symptoms refractory to alpha-antagonists. South Med J. 2000 Dec;93(12):1192–1196. PMID: 11142455.
   PubMed Web of Science ®Google Scholar
• Rassweiler J, Teber D, Kuntz R, et al. Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol. 2006 Nov;50(5):969–979.
   PubMed Web of Science ®Google Scholar
• EB G, Shukla D, KT R, et al. Rezum therapy for patients with large prostates (≥ 80 g): initial clinical experience and postoperative outcomes. World J Urol. 2021 Aug;39(8):3041–3048. Epub 2021 Jan 3. PMID: 33392646; PMCID: PMC7779102.
   PubMed Web of Science ®Google Scholar
• Couteau N, Duquesne I, Frédéric P, et al. and benign prostatic hyperplasia: an impossible compromise? A comprehensive review. J Clin Med. 2021 Dec 10;10;24:5788. PMID: 34945084; PMCID: PMC8704358.
   Google Scholar
• Hellstrom WJ, Sikka SC. Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol. 2006;176:1529–1533.
   PubMed Web of Science ®Google Scholar
• Lokeshwar SD, Valancy D, Lima TFN, et al. Review of reported ejaculatory dysfunction in clinical trials evaluating minimally invasive treatment modalities for BPH. Curr Urol Rep. 2020 Oct26;21(12):54. PMID: 33104947.
   PubMed Web of Science ®Google Scholar